Initial panitumumab plus fluorouracil, leucovorin, and oxaliplatin or plus fluorouracil and leucovorin in elderly patients with RAS and BRAF wild-type metastatic …
S Lonardi, C Rasola, R Lobefaro, D Rossini… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To verify whether both doublet chemotherapy with a modified schedule of
fluorouracil, leucovorin, and oxaliplatin (mFOLFOX) and monochemotherapy with …
fluorouracil, leucovorin, and oxaliplatin (mFOLFOX) and monochemotherapy with …
[HTML][HTML] The Incidence of Hematological Toxicities in Colorectal Cancer Patients Treated With Fluoropyrimidine-Based Regimens at Princess Noorah Oncology Center
M Khan, S Alharbi, S Aljuhani, M Tunkar, A Morya… - Cureus, 2023 - ncbi.nlm.nih.gov
Background Fluoropyrimidine-based regimens are used for the management of colorectal
cancer, which is the second most common cancer in Saudi Arabia. We aimed to study the …
cancer, which is the second most common cancer in Saudi Arabia. We aimed to study the …
Optimierung der Systemtherapie gastrointestinaler Tumoren mit Fokus auf das metastasierte kolorektale Karzinom
A Kurreck - 2023 - refubium.fu-berlin.de
Die vorliegende Habilitationsschrift umfasst die Darstellung der geleisteten
wissenschaftlichen Arbeit im Kontext des gegenwärtigen Forschungsstandes. Im Anschluss …
wissenschaftlichen Arbeit im Kontext des gegenwärtigen Forschungsstandes. Im Anschluss …
Effects of Short Chain Fatty Acids Butyrate and Propionate on Colorectal Cancer Cell Lines in Combination with 5-FU Treatment and Glucose Starvation
C Halvorsen - 2024 - uis.brage.unit.no
Colorectal cancer (CRC) is an increasing global health concern, ranking as the third most
common cancer worldwide and the second leading cause of cancer related mortality. One of …
common cancer worldwide and the second leading cause of cancer related mortality. One of …